At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
MDI - self-rating inventoryother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of Major Depression Inventory (MDI) in Measuring Preoperative Depressive Symptoms in Breast Cancer Patients
In Brief
An observational study evaluating MDI - self-rating inventory for Depression and Depressive Symptoms. Completed, enrolled 21 participants across 1 site.
Detailed Summary
The purpose of this study is to measure depressive symptoms in breast cancer patients before surgery with Major Depression Inventory (MDI). The investigators hypothesize that this patient group will not produce scores correlating to having a mild, moderate or severe depression even though they have just recently experienced a major life crisis by receiving a malignant diagnosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Depressive Symptoms
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedJan 2011
Primary CompletionMar 2011
TodayJul 2026
First PostedJan 27, 2011
Enrollment StartJan 1, 2011
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.4 years ago
Interventions
MDI - self-rating inventoryother
MDI with 12 questions to be completed approximately 1 week before surgery